FIA
MBIO icon

FNY Investment Advisers’s Mustang Bio MBIO Stock Holding History

FNY Investment Advisers’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-267
Closed -$664K – 888
2021
Q1 		$664K Hold
267
– – 0.25% 88
2020
Q4 		$757K Sell
267
-133
-33% -$318K 0.21% 111
2020
Q3 		$945K Buy
400
+67
+20% +$165K 0.4% 67
2020
Q2 		$795K Buy
333
+66
+25% +$154K 0.46% 55
2020
Q1 		$536K Buy
267
+94
+54% +$241K 0.41% 57
2019
Q4 		$530K Buy
173
+40
+30% +$91.6K 0.16% 94
2019
Q3 		$326K Sell
133
-134
-50% -$367K 0.1% 114
2019
Q2 		$736K Buy
+267
New +$762K 0.22% 61

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Investment Advisers's MBIO Position: Q2 2021 in Review

FNY Investment Advisers sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 267 shares — an estimated $664K sold.

FNY Investment Advisers first reported a position in MBIO in Q2 2019 and held it in 8 quarters. The position peaked at $945K in Q3 2020. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

  • FNY Investment Advisers reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 267 Mustang Bio shares in Q2 2021, an estimated $664K.
  • FNY Investment Advisers first reported a position in Mustang Bio in Q2 2019 and held it in 8 quarters.
  • FNY Investment Advisers's Mustang Bio position peaked at $945K in Q3 2020.
  • 92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on FNY Investment Advisers's 13F filing for Q2 2021, filed 14 Jul 2021.